Rain Therapeutics trading resumes
PremiumThe FlyRain Therapeutics trading resumes
11M ago
Rain Oncology to be Acquired by Pathos AI for $1.16 in cash per share
Premium
The Fly
Rain Oncology to be Acquired by Pathos AI for $1.16 in cash per share
11M ago
Rain Therapeutics trading halted, news pending
Premium
The Fly
Rain Therapeutics trading halted, news pending
11M ago
Roth MKM biotech analysts to hold analyst/industry conference call
PremiumThe FlyRoth MKM biotech analysts to hold analyst/industry conference call
2y ago
Roth MKM biotech analysts to hold analyst/industry conference call
Premium
The Fly
Roth MKM biotech analysts to hold analyst/industry conference call
2y ago
Roth MKM biotech analysts to hold analyst/industry conference call
Premium
The Fly
Roth MKM biotech analysts to hold analyst/industry conference call
2y ago
Rain Oncology price target raised to $19 from $12 at H.C. Wainwright
PremiumThe FlyRain Oncology price target raised to $19 from $12 at H.C. Wainwright
2y ago
Rain Oncology reports Q4 EPS (70c), consensus (56c)
Premium
The Fly
Rain Oncology reports Q4 EPS (70c), consensus (56c)
2y ago
TipRanks ‘Perfect 10’ List: There’s an Opportunity Brewing in These 2 Stocks
Premium
Stock Analysis & Ideas
TipRanks ‘Perfect 10’ List: There’s an Opportunity Brewing in These 2 Stocks
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100